Pliant Therapeutics, a Californian biopharma focused on discovering and developing fibrosis drugs, saw its shares close down ...

CANTON − Latrice Snodgrass, the new executive director of the Beacon Charitable Pharmacy, says one of her main goals is to make more people aware of the place she calls "a hidden gem." ...

The FDA has granted RMAT designation to Beacon Therapeutics’ gene therapy, laru-zova, for treating X-linked retinitis ...

UK-headquartered Beacon Therapeutics has raised a whopping $170 million in second-round financing that will be used to advance a gene therapy for an inherited cause of blindness through a pivotal ...

Pliant Therapeutics Inc. (PLRX) suffered a major blow on Friday, with its shares tumbling nearly 35% in regular trading and plunging ...

Hydreight Technologies Inc. (TSXV: NURS) ("Hydreight" or the "Company"), a North American, fully integrated, mobile clinical network of nurses, doctors, and pharmacy distribution, is pleased to ...

LONDON and CAMBRIDGE, Mass., Jan. 28, 2025 /PRNewswire/ -- Beacon Therapeutics Holdings Limited ('Beacon Therapeutics' or 'the Company'), a leading ophthalmic gene therapy company with a mission ...

Beacon MedTech Solutions recently announced that Phil Littlefield will serve as director of operations, effective immediately. With a track record of success in global manufacturing, ...

One such exporter is Beacon Pharmaceuticals, founded in 2006, which became the first company in Bangladesh to export cancer drugs. “It was founder Mohammad Ebadul Karim’s vision to transform ...

Pliant Therapeutics (PLRX) announced that following a prespecified data review and recommendations by the trial’s independent Data Safety ...